help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplowitz, P. B.
Right arrow Articles by D'Ercole, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplowitz, P. B.
Right arrow Articles by D'Ercole, A. J.

Journal of Clinical Endocrinology & Metabolism, Vol 55, 741-748, Copyright © 1982 by Endocrine Society


ARTICLES

Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C

PB Kaplowitz and AJ D'Ercole

Leprechaunism is a rare inherited disorder characterized by severe intrauterine growth retardation and insulin resistance. Cultured skin fibroblasts from an infant with Leprechaunism were previously reported to show decreased stimulation of DNA synthesis by insulin despite apparently normal binding of [125I]insulin and [125I]somatomedin C. We have now further investigated the growth of this patient's fibroblasts and compared their metabolic responses to insulin and various peptide growth factors with responses in normal foreskin-derived fibroblasts. The doubling time of Leprechaun fibroblasts was prolonged (90 vs. 29 h), and their morphology was abnormal. Stimulation of [3H]glucose uptake was minimal with low insulin levels (1--10 ng/ml) relative to controls, but was comparable at higher insulin concentrations (1--10 micrograms/ml). Stimulation of [3H] aminoisobutyric acid uptake by insulin, epidermal growth factor (EGF), multiplication-stimulating activity, and somatomedin C (Sm-C) in Leprechaun cells was diminished relative to control cells at all concentrations tested. Furthermore, stimulation of [3H]thymidine incorporation in Leprechaum cells by EGF, Sm-C, and fibroblast growth factor was also subnormal. Binding of [125I]EGF to Leprechaun fibroblasts was not decreased. It is concluded that fibroblasts from this patient are resistant to the metabolic effects of insulin, EGF, Sm-C, and fibroblast growth factor. Since receptors for three of these peptides are apparently normal, it is likely that the defect in these cells is at the postreceptor level, perhaps involving a metabolic pathway common to the action of multiple growth factors.


This article has been cited by other articles:


Home page
DiabetesHome page
H. S. Park, D. K. Jin, S. M. Shin, M. K. Jang, N. Longo, J. W. Park, D. S. Bae, and Y. S. Bae
Impaired Generation of Reactive Oxygen Species in Leprechaunism Through Downregulation of Nox4
Diabetes, November 1, 2005; 54(11): 3175 - 3181.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Jain, D. W. Golde, R. Bailey, and M. E. Geffner
Insulin-Like Growth Factor-I Resistance
Endocr. Rev., October 1, 1998; 19(5): 625 - 646.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
Y. Takahashi, K. Tobe, H. Kadowaki, D. Katsumata, Y. Fukushima, Y. Yazaki, Y. Akanuma, and T. Kadowaki
Roles of Insulin Receptor Substrate-1 and Shc on Insulin-Like Growth Factor I Receptor Signaling in Early Passages of Cultured Human Fibroblasts
Endocrinology, February 1, 1997; 138(2): 741 - 750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society